In patients with cancer as well as depression and fatigue, there are also elevated circulating inflammatory cytokines, and peripheral blood interleukin (IL)-1β, IL-6, tumor necrosis factor, and CRP levels show an increasing trend [60,61]. Here, IL6 is linked to depressive symptom measurement.